Controversial Issues and Challenging Cases in the New Frontier of Obesity Online Activity
Release date: December 5, 2013
Expiration date: December 5, 2014
Estimated time to complete activity: 1 hour
Course viewing requirements:
PC: Internet Explorer (v6 or greater), Google Chrome, or Firefox
MAC: Safari or Firefox
Jointly sponsored by Postgraduate Institute for Medicine (www.pimed.com) and Medtelligence, LLC
This activity is supported by an educational grant from Eisai Inc.
Daniel H. Bessesen, MD
Professor of Medicine, Department of Medicine
Division of Endocrinology, Metabolism and Diabetes
University of Colorado, School of Medicine
Chief of Endocrinology, Denver Health Medical Center
W. Timothy Garvey, MD
Professor of Medicine
Chair, Department of Nutrition Sciences
Director, UAB Diabetes Research Center
Associate Director, Nutrition Obesity Research Center
University of Alabama at Birmingham
Michelle Look, MD, FAAFP
Family Practice-Sports Medicine
Medical Director of Clinical Research
San Diego Sports Medicine and Family Health Center
San Diego, CA
Domenica Rubino, MD
Director and Founder
Washington Center for Weight Management & Research
This activity has been designed to meet the educational needs of Primary Care Physicians, Family Practice Physicians, and other healthcare professionals who manage patients or work in a health system related to weight management and obesity.
Obesity has become a world-wide issue of utmost importance as its incidence and prevalence are associated with dramatic increases in higher medical costs and poorer health outcomes. With recent endorsements of the medicalization of obesity as a disease and new consensus statements on its pathophysiology and management, clinicians will be better prepared to meet the needs of this 21st century scourge. This online activity, based on a live meeting on September 26, 2013 in San Diego, CA, showcases acclaimed expert educators addressing key clinical issues and cases on obesity management.
After completing this activity, the participant should be better able to:
Physician Continuing Education
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Medtelligence, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Daniel H. Bessesen, MD: Data and Safety Monitoring Board: EnteroMedics
W. Timothy Garvey, MD: Consulting Fees: Alkermes, Daiichi-Sankyo, Eisai, Janssen, LipoScience, Novo Nordisk, VIVUS; Fees for Non-CME/CE Services: Amylin, Eisai, Merck; Contracted Research: Amylin, Merck, Weight Watchers; Ownership Interest: Isis, Lilly, Merck, Novartis, Pfizer, VIVUS
Robert F. Kushner, MD, MS: Receipt of Intellectual Property Rights: Retrofit; Consulting Fees: Novo Nordisk, VIVUS, Zafgen; Contracted Research: Aspire Bariatrics, Weight Watchers
Michelle Look, MD: Consulting Fees: VIVUS; Fees for Non-CME/CE Services: VIVUS; Ownership Interest: Arena, VIVUS
Domenica Rubino, MD: Speaker’s Bureau: Eisai
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Medtelligence, LLC: Ben Caref, PhD; Pamela Clark - No financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation and Request for Credit
There are no fees for participating and receiving CME credit for this activity. During the period December 1, 2013 through November 30, 2014, participants must read the learning objectives and faculty disclosures and study the educational activity.
PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID #9578. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.
Click on the sections below to review the audio and slides and to take the post-test. All audio was recorded at the live meeting on September 26, 2013 in San Diego, CA.
|Drs. Rubino and Look describe treatment options
for the medical management of obesity. (26 minutes)
|Drs. Garvey and Look examine the association of obesity with co-morbidities. (12 minutes)||Drs. Kushner, Bessesen, Garvey, Look, and Rubino address audience questions regarding weight-loss medications and risk factor reduction. (8 minutes)||Take the post-test to earn CME credit. Use ID #9578.|